clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT01425905 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | United States of America | Q30 |
P582 | end time | 2015-08-10 | |
P921 | main subject | major depressive disorder | Q42844 |
obesity | Q12174 | ||
Type 2 diabetes risk allele near CENTD2 is associated with decreased glucose-stimulated insulin release | Q57730687 | ||
P4135 | maximum age | 17 | |
P1050 | medical condition | glucose intolerance | Q2661464 |
P2899 | minimum age | 12 | |
P1132 | number of participants | 174 | |
P6153 | research site | National Institutes of Health | Q390551 |
P859 | sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development | Q5409765 |
P580 | start time | 2011-08-23 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Mood and Insulin Resistance in Adolescents At-Risk for Diabetes |
Search more.